Label Changes for:

Aceon (perindopril erbumine) Tablets

February 2013

Changes have been made to the CONTRAINDICATIONS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – 

 

February 2013

 

CONTRAINDICATIONS

  • Do not co-administer aliskiren with Aceon in patients with diabetes
 
Hide
(web1)